Peptide COA Purity Testing: Why the Numbers Lie
A certificate of analysis is supposed to be your proof that a peptide is what the seller claims — but a viral experiment this week showed the same vial sent to three different labs came back as 91% pure, 94% pure, and 97.8% pure.
A certificate of analysis is supposed to be your proof that a peptide is what the seller claims — but a viral experiment this week showed the same vial sent to three different labs came back as 91% pure, 94% pure, and 97.8% pure. Those numbers cannot all be right, and the gap between them is not a rounding error. It is a window into a structural problem with how peptide purity is measured, reported, and — sometimes — never actually verified at all. If you are using peptides for longevity, body composition, or recovery, understanding why COA numbers are method-dependent rather than absolute is one of the most practical things you can do to protect yourself. Vitals Vault's lab panel and PocketMD clinicians can help you track what is actually happening in your body while you sort out what is in the vial.
Why this is trending
A Reddit thread in the longevity community documenting a live three-lab split-vial comparison set off a wave of discussion this week, with researchers, biohackers, and skeptics all landing on the same uncomfortable question: if the same physical sample produces three meaningfully different purity readings, what does a COA actually certify? Longevity researcher Matt Kaeberlein has also been pushing back publicly on the gap between peptide policy and peptide data, which has kept the credibility question front and center. This is not a new problem — analytical chemists have known for years that purity figures are inseparable from the method used to generate them — but it is newly visible to a consumer audience that has been told to 'always ask for a COA' without being told what a COA can and cannot prove.
What a Peptide COA Actually Is
A COA is a lab report, not a guarantee
A certificate of analysis is a document from a testing laboratory stating that a sample met certain specifications on the day it was tested. It does not mean the product in your hands came from that sample, was stored correctly afterward, or was tested using a method rigorous enough to catch common contaminants.
Purity percentage is method-dependent, not absolute
The most common testing approach is called high-performance liquid chromatography (HPLC), which separates a peptide's components and measures their relative peaks. The problem is that different HPLC setups — different column types, solvent gradients, and detection wavelengths — can produce genuinely different purity numbers from the same sample, which is exactly what the three-lab experiment revealed.
Chain of custody is the gap nobody mentions
Even a perfectly accurate COA only certifies the batch that was tested, not every vial filled from that batch afterward. If a vendor tests one sample from a large synthesis run and then sells hundreds of vials, the COA travels with all of them — but the testing did not. Degradation during shipping, repackaging, or storage can change what is in the vial without changing the paperwork.
Lab testing
Your peptide's COA tells you nothing about what is happening inside your body. A Vitals Vault starting-from-$99 panel with 100+ tests, one visit can show you kidney function, liver enzymes, inflammatory markers, and hormones
the signals that actually tell you whether something is working or causing harm
About 1 week
Schedule online — results typically within a week
Clear next steps
Guidance included, with follow-up care available
HSA / FSA
Eligible for pre-tax health spending accounts
Why This Is Blowing Up Right Now
A real experiment produced three different answers
The Reddit thread that sparked this wave of discussion was not theoretical — a user documented sending the same physical vial's contents to three separate commercial labs and photographed all three COAs side by side. Getting 91%, 94%, and 97.8% from one sample made the method-dependence problem impossible to dismiss as academic.
Peptide use has moved from research labs to living rooms
Compounds like BPC-157, TB-500, and semaglutide analogs have gone from niche research chemicals to mainstream wellness products in just a few years, which means millions of people are now relying on COA literacy they were never taught. The consumer base has scaled faster than the quality-assurance infrastructure around it.
Researchers are publicly questioning the regulatory vacuum
Voices like Matt Kaeberlein have been drawing attention to the mismatch between the political treatment of peptides and the actual evidence base, and that conversation naturally pulls in questions about data quality — including whether the purity data vendors provide is meaningful at all.
How the Testing Methods Actually Differ
HPLC measures relative peaks, not absolute identity
When a lab runs HPLC, it is measuring how much of the detected signal belongs to the main compound versus everything else in the sample. But if a contaminant absorbs light poorly at the wavelength the detector uses, it can be nearly invisible — meaning the peptide looks 97% pure when it is not. The choice of detection wavelength alone can shift a purity reading by several percentage points.
Mass spectrometry confirms identity but not quantity
Mass spectrometry (MS) tells you whether the correct molecular structure is present in the sample, which is genuinely useful — but it is not a purity measurement on its own. A sample can contain the right peptide alongside wrong ones, and MS without quantification will not tell you the ratio. The gold standard is combining both methods, but many vendors only provide one.
Reference standards determine how accurate any method can be
Every purity measurement is only as good as the reference standard the lab uses to calibrate against. For well-established pharmaceuticals, certified reference standards exist. For many research peptides, they do not — which means labs are calibrating against their own in-house preparations, and two labs using different internal standards will produce different numbers even if their instruments are identical.
Who Should Actually Care About This
Anyone using peptides for a health outcome, not just curiosity
If you are taking a peptide because you expect a specific physiological effect — better recovery, improved insulin sensitivity, reduced inflammation — then purity matters directly to your outcome. A vial that is 85% your intended compound and 15% unknown byproducts is not delivering the dose you think it is, and the byproducts are doing something, even if you do not know what.
People who have been told 'just check the COA' and stopped there
The COA-check advice is well-intentioned but incomplete. Knowing that a COA exists is not the same as knowing it was generated by an accredited lab, used an appropriate method, tested the actual batch you received, or was not simply copied from a previous lot. Asking vendors which specific analytical method was used and whether the testing lab is ISO 17025 accredited are the follow-up questions that actually matter.
Clinicians and patients navigating compounded peptide prescriptions
Even compounded peptides from licensed pharmacies — which face more regulatory oversight than research-chemical vendors — can vary in purity depending on the compounding pharmacy's quality controls. If you are working with a clinician on a peptide protocol, asking whether the pharmacy provides method-specific COAs and what their internal testing frequency looks like is a reasonable and appropriate question.
What the Purity Problem Actually Puts at Risk
Unknown impurities are not just inert filler
Synthesis byproducts in peptide manufacturing can include truncated sequences, oxidized variants, or residual solvents — none of which are tested for by a standard HPLC purity run. Some of these impurities are biologically active in ways that are difficult to predict, and because they are not on the COA, you have no way to know you are being exposed to them.
Dosing math breaks down when purity is uncertain
If you are working with a clinician who has calculated a dose based on a stated purity of 98% and the actual purity is closer to 88%, you are getting roughly 10% less active compound per injection — but the impurity load is higher than expected. This matters most for peptides with narrow therapeutic windows or when you are trying to interpret why something is or is not working.
A COA from an unaccredited lab is not a safety document
Some vendors use in-house testing or contract labs that are not independently accredited, which means there is no third-party verification that the lab's methods are valid or that the results were not simply generated to match a target number. Looking for ISO 17025 accreditation on the testing lab — not just the vendor — is the single most useful filter available to consumers right now.
Frequently Asked Questions
Can I trust a COA that shows 99% purity for a peptide?
Not without knowing how that number was generated. A 99% purity figure from an HPLC run using a single UV wavelength can miss contaminants that absorb poorly at that wavelength, so the real-world purity may be lower. Ask which analytical method was used, whether the testing lab is ISO 17025 accredited, and whether the lot number on the COA matches the vial you received.
Why did the same peptide sample get three different purity readings from three labs?
Because purity is not a fixed property of a substance — it is a measurement, and measurements depend on the method, equipment, calibration standards, and detection settings used. Different HPLC column types and detection wavelengths can produce genuinely different peak ratios from the same sample, which is why the three-lab experiment returned 91%, 94%, and 97.8% without any lab necessarily being dishonest.
What is the difference between HPLC and mass spectrometry for peptide testing?
HPLC separates the components of a sample and measures their relative quantities, giving you a purity percentage — but it can miss contaminants that are hard to detect at the chosen wavelength. Mass spectrometry confirms whether the correct molecular structure is present but does not quantify how much of it is there relative to impurities. The most informative COAs combine both methods.
How do I know the vial I received was actually from the batch that was tested?
You often cannot know for certain, which is the chain-of-custody problem. The best you can do is verify that the lot number on the COA matches the lot number printed on your vial, ask the vendor how many vials were filled from the tested batch, and check whether the testing lab is accredited rather than in-house. If a vendor cannot answer those questions, that itself is informative.
Should I get blood work done if I am using peptides?
Yes — tracking markers like liver enzymes, kidney function, inflammatory proteins, and relevant hormones before and during peptide use gives you objective data on whether something is working or causing harm, regardless of what the COA says. A Vitals Vault panel can capture all of those markers in a single visit, and a PocketMD clinician can help you interpret what the results mean for your specific protocol.